Taysha Gene Therapies(TSHA) - 2022 Q4 - Earnings Call Transcript

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Hayleigh Collins - Director and Head of Corporate Communications Sean Nolan - Chief Executive Officer Sukumar Nagendran - President and Head of Research and Development Kamran Alam - Chief Financial Officer Conference Call Participants Whitney Ijem - Canaccord Genuity Jack Allen - Robert W. Baird & Co. Silvan Tuerkcan - JMP Securities Yun Zhong - BTIG David Hoang - SMBC Nikko Securities ...